Burning Rock Biotech Limited Accounts Receivable, before Allowance for Credit Loss, Current
Burning Rock Biotech Limited (BNR) had Accounts Receivable, before Allowance for Credit Loss, Current of CNY 228.87 million as of 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableGrossCurrent · last filed 2026-04-28
- 2025-12-31: Accounts Receivable, before Allowance for Credit Loss, Current 228.87M CNY.
- 2024-12-31: Accounts Receivable, before Allowance for Credit Loss, Current 197.88M CNY.
- 2023-12-31: Accounts Receivable, before Allowance for Credit Loss, Current 165.25M CNY.
- 2022-12-31: Accounts Receivable, before Allowance for Credit Loss, Current 152.87M CNY.
CNY
| Period end | Accounts Receivable, before Allowance for Credit Loss, Current |
|---|---|
| 2025-12-31 | 228.87M CNY 20-F · filed 2026-04-28 |
| 2024-12-31 | 197.88M CNY 20-F · filed 2026-04-28 |
| 2023-12-31 | 165.25M CNY 20-F · filed 2025-04-29 |
| 2022-12-31 | 152.87M CNY 20-F · filed 2024-04-29 |
| 2022-06-30 | 145.78M CNY 6-K · filed 2022-11-07 |
| 2021-12-31 | 131.36M CNY 20-F · filed 2023-04-20 |
| 2020-12-31 | 112.43M CNY 20-F · filed 2022-04-29 |
| 2019-12-31 | 101.93M CNY 20-F · filed 2021-03-23 |
USD
| Period end | Accounts Receivable, before Allowance for Credit Loss, Current |
|---|---|
| 2025-12-31 | $32.73M 20-F · filed 2026-04-28 |
| 2024-12-31 | $27.11M 20-F · filed 2025-04-29 |
| 2023-12-31 | $23.28M 20-F · filed 2024-04-29 |
| 2022-12-31 | $22.16M 20-F · filed 2023-04-20 |
| 2022-06-30 | $21.77M 6-K · filed 2022-11-07 |
| 2021-12-31 | $20.61M 20-F · filed 2022-04-29 |
| 2020-12-31 | $17.23M 20-F · filed 2021-03-23 |